Excellent long-term virological and clinical response in HDV compensated cirrhotics treated with high dose Bulevirtide beyond 2.5 years: A case series. (March 2021) - Loglio, A.; Ferenci, P.; Renteria, SC. Uceda; Holzmann, H.; Borghi, M.; Perbellini, R.; Rimondi, A.; Trombetta, E.; Giovanelli, S.; Porretti, L.; Prati, D.; Ceriotti, F.; et al.